These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 15705637

  • 1. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, Alonso R, del Valle O, Hernández-Molina JM, McNicholas P, Loebenberg D, Santos P.
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of disc diffusion assay with the CLSI reference method (M27-A2) for testing in vitro posaconazole activity against common and uncommon yeasts.
    Cantón E, Pemán J, Espinel-Ingroff A, Martín-Mazuelos E, Carrillo-Muñoz A, Martínez JP.
    J Antimicrob Chemother; 2008 Jan; 61(1):135-8. PubMed ID: 18033784
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans.
    Pfaller MA, Messer SA, Hollis RJ, Jones RN.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2862-4. PubMed ID: 11557481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [Abstract] [Full Text] [Related]

  • 13. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
    Matsumoto FE, Dias AL, Melhem MS, Szeszs MW, Auler ME, Ruiz LS, Gonçalves da Silva E, Gandra RF, Paula CR.
    Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
    Seifert H, Aurbach U, Stefanik D, Cornely O.
    Antimicrob Agents Chemother; 2007 May; 51(5):1818-21. PubMed ID: 17307977
    [Abstract] [Full Text] [Related]

  • 15. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates.
    Claudino AL, Peixoto RF, Melhem MS, Szeszs MW, Lyon JP, Chavasco JK, Franco MC.
    Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002.
    Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2005 Mar; 51(3):179-83. PubMed ID: 15766603
    [Abstract] [Full Text] [Related]

  • 18. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
    Borman AM, Muller J, Walsh-Quantick J, Szekely A, Patterson Z, Palmer MD, Fraser M, Johnson EM.
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
    [Abstract] [Full Text] [Related]

  • 19. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
    Rautemaa R, Richardson M, Pfaller MA, Perheentupa J, Saxén H.
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
    [Abstract] [Full Text] [Related]

  • 20. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
    Espinel-Ingroff A.
    J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.